en · de · es · fr · pt
analytical-notes.peptides7501.com › Topic › Semax Peptide Background And Identity — Beginner to Advanced

Semax Peptide Background And Identity — Beginner to Advanced

By Editorial Desk · published 2025-08-11 · last reviewed 2025-09-25 · Topic

The short version of nasal drops fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-09-25 and is reviewed periodically as new material appears.

Semax Peptide Background and Identity

Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.

Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.

Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.

Semax Background and Molecular Structure

Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.

Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.

The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.

Semax at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptide (ACTH fragment analog)Not a steroid; does not belong to the melanocortin agonist drugs by marketing category
Molecular formulaC37H51N9O10S (commonly cited)Reported values vary slightly with salt and counter-ion content
AppearanceWhite to off-white lyophilized powderA single batch may appear as a loose cake or fluffy solid
SolubilityFreely soluble in water and aqueous bufferStock solutions are usually prepared in sterile water or saline
Typical storage−20 °C or below, desiccated and protected from lightSeal opened vials promptly to limit moisture uptake

Background and Development History

The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

Related pages on this site

Semax Background And Mechanism

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.

The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.

Further detail

===== MeSH D08.811.682.655 – nitroreductases ===== MeSH D08.811.682.655.249 – gmp reductase MeSH D08.811.682.655.500 – nitrate reductases MeSH D08.811.682.655.500.124 – nitrate reductase MeSH D08.811.682.655.500.200 – nitrate reductase (nadh) MeSH D08.811.682.655.500.249 – nitrate reductase (nad(p)h) MeSH D08.811.682.655.500.374 – nitrate reductase (nadph) MeSH D08.811.682.655.750 – nitrite reductases MeSH D08.811.682.655.750.249 – ferredoxin-nitrite reductase MeSH D08.811.682.655.750.500 – nitrite reductase (NAD(P)H)

The resulting viral mRNA looks is identical to host mRNA, allowing endogenous cellular machinery to carry out processing and nuclear export. The de-capped host mRNAs are targeted degradation, which lead to the downregulation of cellular mRNA. Influenza RdRp also interacts with the cell Polymerase II (Pol II) C terminal domain, which potentially promotes viral transcription by changing the conformation of the RdRp. Additionally, by reducing Pol II abundance, influenza can begin to shut off critical host transcription. Cap snatching is not used during replication. Instead, the RdRp performs a "prime and realign" step ensure that the genome is fully copied. In this mechanism, the RdRp sets down a primer internally, then the vRNA is realigned to continue replication. Influenza's PB2 cap-binding domain has a unique fold, but it uses aromatic stacking to execute m7G cap-binding similar to other cap-binding proteins. PA is a member of the PD(D/E)XK nuclease family, which uses divalent metal ions to cleave nucleic acid. However, it has a peculiar active site histidine residue which ligates the Mn2+ ion used for cleavage.

Intravascular hemolysis describes hemolysis that happens mainly inside the vasculature. As a result, the contents of the red blood cell are released into the general circulation, leading to hemoglobinemia and increasing the risk of ensuing hyperbilirubinemia. Intravascular hemolysis may occur when red blood cells are targeted by autoantibodies, leading to complement fixation, or by damage by parasites such as Babesia. Additionally, thrombotic microangiopathy (TMA) can result in hemolysis of red blood cells. TMA is frequently observed in aHUS patients where clots form in the small vessels of the kidney resulting in damaged red blood cells as they attempt to pass through the restricted vessels.

The Rhizoplaca melanophthalma complex (rock-posy lichens) illustrates this complexity. Formerly treated as one circumpolar species with variable forms, the group is now recognized as several genetically distinct but partly hybridising species. Keuler and colleagues (2020) used genome-scale data and detected at least three historic hybridisation events. Network analysis showed that one lineage, Rhizoplaca shushanii, arose from hybridisation between R. melanophthalma and R. parilis and that low-level gene flow still occurs among some lineages. The hybrids lineages have unusual traits: R. shushanii is an alpine endemic with a distinct appearance, and two other lineages that were involved in introgression (gene flow between species) (R. haydenii and R. arbuscula) are vagrant forms that do not attach to rock but blow around on soil and reproduce only asexually. The study found discordance between nuclear and mitochondrial DNA trees (mitochondria from one species had introgressed into another), and the authors suggest that hybridization events might be linked to the loss of sexual reproduction and the evolution of these unusual, unattached growth forms. Systematically, the case shows that species boundaries can be porous and that reticulate evolution must be tested—single-locus barcodes can mislead when hybridisation is present. It also shows why relying on a single genetic locus (such as the ITS barcode alone) can be misleading: different genes in the same organisms have different histories if hybrids are involved.

The tumor-suppressor protein p53 accumulates when DNA is damaged due to a chain of biochemical factors. Part of this pathway includes alpha-interferon and beta-interferon, which induce transcription of the p53 gene, resulting in the increase of p53 protein level and enhancement of cancer cell-apoptosis. p53 prevents the cell from replicating by stopping the cell cycle at G1, or interphase, to give the cell time to repair; however, it will induce apoptosis if damage is extensive and repair efforts fail. Any disruption to the regulation of the p53 or interferon genes will result in impaired apoptosis and the possible formation of tumors.

Sources: en.wikipedia.org

Supporting material

Carbon is distributed throughout the atmosphere, the biosphere, and the oceans; these are referred to collectively as the carbon exchange reservoir, and each component is also referred to individually as a carbon exchange reservoir. The different elements of the carbon exchange reservoir vary in how much carbon they store, and in how long it takes for the 14C generated by cosmic rays to fully mix with them. This affects the ratio of 14C to 12C in the different reservoirs, and hence the radiocarbon ages of samples that originated in each reservoir. The atmosphere, which is where 14C is generated, contains about 1.9% of the total carbon in the reservoirs, and the 14C it contains mixes in less than seven years. The ratio of 14C to 12C in the atmosphere is taken as the baseline for the other reservoirs: if another reservoir has a lower ratio of 14C to 12C, it indicates that the carbon is older and hence that either some of the 14C has decayed, or the reservoir is receiving carbon that is not at the atmospheric baseline. The ocean surface is an example: it contains 2.4% of the carbon in the exchange reservoir, but there is only about 95% as much 14C as would be expected if the ratio were the same as in the atmosphere. The time it takes for carbon from the atmosphere to mix with the surface ocean is only a few years, but the surface waters also receive water from the deep ocean, which has more than 90% of the carbon in the reservoir.

=== Round-trip efficiency === The table below shows the result of an experimental evaluation of a "high-energy" type 3.0 Ah 18650 NMC cell in 2021, round-trip efficiency which compared the energy going into the cell and energy extracted from the cell from 100% (4.2v) SoC to 0% SoC (cut off 2.0v). A round-trip efficiency is the percent of energy that can be used relative to the energy that went into charging the battery.

==== Backup site ==== A backup site or disaster recovery center is used to store data that can enable computer systems and networks to be restored and properly configured in the event of a disaster. Some organisations have their own data recovery centres, while others contract this out to a third-party. Due to high costs, backing up is rarely considered the preferred method of moving data to a DR site. A more typical way would be remote disk mirroring, which keeps the DR data as up to date as possible.

=== Helmholtz === The model dubbed the 'electric double layer' was first introduced by Hermann von Helmholtz. It assumes that a solution is only composed of electrolytes, no reactions occur near the electrode which could transfer electrons, and that the only Van der Waals interactions are present between the ions in solution and the electrode. These interactions arise only due to the charge density associated with the electrode which arises from either an excess or deficiency of electrons at the electrode's surface. To maintain electrical neutrality the charge of the electrode will be balanced by a redistribution of ions close to its surface. The attracted ions thus form a layer balancing the electrode's charge. The closest distance an ion can come to the electrode will be limited to the radius of the ion plus a single solvation sphere around an individual ion. Overall, two layers of charge and a potential drop from the electrode to the edge of the outer layer (outer Helmholtz Plane) are observed. Given the above description, the Helmholtz model is equivalent in nature to an electrical capacitor with two separated plates of charge, for which a linear potential drop is observed at increasing distance from the plates. The Helmholtz model, while a good foundation for the description of the interface does not take into account several important factors: diffusion/mixing in solution, the possibility of adsorption on to the surface and the interaction between solvent dipole moments and the electrode.

Sources: en.wikipedia.org

Notes from published material

== Plot == On the day of her first wedding anniversary, Pallavi travels from San Francisco to Los Angeles to meet her former lover, P. Uma Maheswara Rao, unbeknownst to her husband, Arun. Eighteen months earlier, college-going Pallavi aspires to record a dance performance to show her future family post-marriage. Lacking natural skill, she hires Uma, an orphaned statistics student, to tutor her. Over time, Uma helps Pallavi with her dance, assists her in confronting a bully, and the two fall in love. Pallavi arranges for Uma to stay in her family's penthouse, where he tutors local students to earn money. When her family begins seeking marital alliances, Pallavi proposes eloping. Uma initially agrees, but backs out after witnessing Pallavi's father, Chandramouli, lecture a young boy on the financial and emotional responsibilities of marriage. Realizing he needs stability, Uma leaves for New Delhi to pursue a Ph.D., asking Pallavi to wait. Heartbroken and pressured to marry, Pallavi severs contact and eventually agrees to marry her suitor Arun. A year later, Pallavi learns from Uma's former professor that Uma has fallen into severe depression and alcoholism. Feeling responsible, she travels to Los Angeles to confront him. In Los Angeles, Pallavi insists she is happily married, but Uma refuses to believe her. To prove her happiness, Pallavi invites Uma to stay with her and Arun in San Francisco for 10 days with Arun's consent. Uma accepts on the condition that if he fails to see genuine love between the couple, Pallavi must leave him.

McQuillan, Discharge residues from cartridge-operated industrial tools, J. Forens. Sci. Soc. 24 (1984) 495–508. J.S. Wallace, Chemical Analysis of Firearms, Ammunition, and Gunshot Residue, (2008) CRC Press LLC. G.M. Wolten, R.S. Nesbitt, A.R. Calloway, G.L. Loper, P.F. Jones, Particle analysis for the detection of gunshot residue. I: Scanning electron microscopy/energy dispersive X-ray characterisation of hand deposits from firing, J. Forens. Sci. 24 (1979) 409–422. G.M. Wolten, R.S. Nesbitt, A.R. Calloway, G.L. Loper, Particle analysis for the detection of gunshot residue. II: occupational and environmental particles, J. Forens. Sci. 24 (1979) 423–430. G.M. Wolten, R.S. Nesbitt, A.R. Calloway, Particle analysis for the detection of gunshot residue. III: the case record, J. Forens. Sci. 24 (1979) 864–869.

germ cell Any cell that gives rise to the gametes of a sexually reproducing organism. Germ cells are the vessels for the genetic material which will ultimately be passed on to the organism's descendants and are usually distinguished from somatic cells, which are entirely separate from the germ line.

Sources: en.wikipedia.org

Frequently asked questions

What is Semax made of?

It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.

Where did Semax originate?

It was developed in the Soviet Union during the early 1980s by groups at the Institute of Molecular Genetics in Moscow. Russian approval for intranasal use followed, and it has been marketed there since. Western laboratories encountered it mainly through translated literature and, later, through online research-chemical trade.

Is Semax a licensed medicine?

It holds a Russian registration as a prescription nasal product but has no approval from the European Medicines Agency or the United States Food and Drug Administration. Buyers outside Russia usually receive material sold strictly for laboratory research. That distinction matters because research-grade and pharmaceutical-grade products carry different documentation and testing expectations.

What is the amino acid sequence of Semax?

The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.

Network